Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-02
2007-01-02
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S452000
Reexamination Certificate
active
10546967
ABSTRACT:
Process for the synthesis of compounds of formula (I):wherein R represents hydrogen or a protecting group.Application in the synthesis of perindopril and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4933361 (1990-06-01), Holger et al.
patent: 2006/0149082 (2006-07-01), Dubuffet et al.
patent: 0937714 (1999-08-01), None
patent: WO 01/58868 (2001-08-01), None
patent: WO03/016336 (2003-02-01), None
M Wincent, et al. “Stereoselective Synthesis of a New Perhydroindole Derivative of Chiral Iminodiacid, a Potent Inhibitor of Agiotensin Converting Enzyme”, Tetrahedron, vol. 23, No. 16, p. 1677-1680, 1982.
International Search Report: PCT FR2004 000444, Aug. 9, 2004.
International Preliminary Examination Report: PCT 2004 000444, Aug. 31, 2004.
International Preliminary Report on Patentability: PCT/FR2004/000444—Sep. 29, 2005.
Dubuffet Thierry
Langlois Pascal
Barker Michael P.
Hueschen and Sage
Les Laboratoires Servier
Shameem Golam M. M.
LandOfFree
Method for synthesissing (2s, 3as,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for synthesissing (2s, 3as,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for synthesissing (2s, 3as,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3759175